PDX models of TNBC have shown that a reversible cell state enriched in a cancer stem-like cell (CSC) gene expression signature arises in drug-refractory breast cancer, and as elevation of MCL-1 occurs in treatment-resistant samples it is tempting to speculate that MCL-1 may facilitate this process [48,49,136,137]. The gene discussed is MCL1; the disease is breast cancer.